Literature DB >> 8636449

Fc gamma RIIA alleles are heritable risk factors for lupus nephritis in African Americans.

J E Salmon1, S Millard, L A Schachter, F C Arnett, E M Ginzler, M F Gourley, R Ramsey-Goldman, M G Peterson, R P Kimberly.   

Abstract

Allelic variants of Fc gamma R confer distinct phagocytic capacities providing a mechanism for heritable susceptibility to immune complex disease. Human Fc gamma RIIa has two codominantly expressed alleles, R131 and H131, which differ substantially in their ability to ligate human IgG2. The Fc gamma RIIa-H131 is the only human Fc gamma R which recognizes IgG2 efficiently and optimal IgG2 handling occurs only in the homozygous state. Therefore, since immune complex clearance is essential in SLE, we hypothesized that Fc gamma RIIA genes are important disease susceptibility factors for SLE, particularly lupus nephritis. In a two-stage cross-sectional study, we compared the distribution of Fc gamma RIIA alleles in African Americans with SLE to that in African American non-SLE controls. A pilot study of 43 SLE patients and 39 controls demonstrated a skewed distribution of Fc gamma RIIA alleles, with only 9% of SLE patients homozygous for Fc gamma RIIa-H131 compared with 36% of controls (odds ratio, 0.18; 95% CI, 0.05-0.69, P = 0.009). This was confirmed with a multicenter study of 214 SLE patients and 100 non-SLE controls. The altered distribution of Fc gamma RIIA alleles was most striking in lupus nephritis. Trend analysis of the genotype distribution showed a highly significant decrease in Fc gamma RIIA-H131 as the likelihood for lupus nephritis increased (P = 0.0004) consistent with a protective effect of the Fc gamma RIIA-H131 gene. The skewing in the distribution of Fc gamma RIIA alleles identifies this gene as a risk factor with pathophysiologic importance for the SLE diathesis in African Americans.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8636449      PMCID: PMC507190          DOI: 10.1172/JCI118552

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  45 in total

1.  Expression of the high responder/non-responder human Fc gamma RII. Analysis by PCR and transfection into FcR-COS cells.

Authors:  B J Tate; E Witort; I F McKenzie; P M Hogarth
Journal:  Immunol Cell Biol       Date:  1992-04       Impact factor: 5.126

Review 2.  Genetics of the complement system and rheumatic diseases.

Authors:  J M Moulds; M Krych; V M Holers; M K Liszewski; J P Atkinson
Journal:  Rheum Dis Clin North Am       Date:  1992-11       Impact factor: 2.670

3.  IgG subclass restriction of autoantibody to solid-phase C1q in membranoproliferative and lupus glomerulonephritis.

Authors:  A E Prada; C F Strife
Journal:  Clin Immunol Immunopathol       Date:  1992-04

4.  On the interaction of IgG subclasses with the low affinity Fc gamma RIIa (CD32) on human monocytes, neutrophils, and platelets. Analysis of a functional polymorphism to human IgG2.

Authors:  P W Parren; P A Warmerdam; L C Boeije; J Arts; N A Westerdaal; A Vlug; P J Capel; L A Aarden; J G van de Winkel
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

5.  Comparison of autoantibodies to the collagen-like region of C1q in hypocomplementemic urticarial vasculitis syndrome and systemic lupus erythematosus.

Authors:  J J Wisnieski; S M Jones
Journal:  J Immunol       Date:  1992-03-01       Impact factor: 5.422

Review 6.  The immunobiology of human Fc gamma receptors on hematopoietic cells and tissue macrophages.

Authors:  A D Schreiber; M D Rossman; A I Levinson
Journal:  Clin Immunol Immunopathol       Date:  1992-01

7.  Receptor specific probes for the study of Fc gamma receptor specific function.

Authors:  J C Edberg; R P Kimberly
Journal:  J Immunol Methods       Date:  1992-04-08       Impact factor: 2.303

8.  Increased proportion of responders to a murine anti-CD3 monoclonal antibody of the IgG1 class in patients with systemic lupus erythematosus (SLE).

Authors:  A M Blasini; I L Stekman; M Leon-Ponte; D Caldera; M A Rodriguez
Journal:  Clin Exp Immunol       Date:  1993-12       Impact factor: 4.330

Review 9.  Human IgG Fc receptor heterogeneity: molecular aspects and clinical implications.

Authors:  J G van de Winkel; P J Capel
Journal:  Immunol Today       Date:  1993-05

10.  The relationship between serum titers of autoantibodies to C1q and age in the general population and in patients with systemic lupus erythematosus.

Authors:  C E Siegert; M R Daha; A J Swaak; E A van der Voort; F C Breedveld
Journal:  Clin Immunol Immunopathol       Date:  1993-06
View more
  105 in total

1.  Immunogenetic risk factors for anti-neutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis.

Authors:  M Gencik; S Borgmann; R Zahn; E Albert; T Sitter; J T Epplen; H Fricke
Journal:  Clin Exp Immunol       Date:  1999-08       Impact factor: 4.330

2.  Fcgamma receptor polymorphisms in populations in Ethiopia and Norway.

Authors:  L Van Den Berg; K M Myhr; B Kluge; C A Vedeler
Journal:  Immunology       Date:  2001-09       Impact factor: 7.397

Review 3.  Diversity and duplicity: human FCgamma receptors in host defense and autoimmunity.

Authors:  Robert P Kimberly; Jianming Wu; Andrew W Gibson; Kaihong Su; Hongwe Qin; Xiaoli Li; Jeffrey C Edberg
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

Review 4.  Genetics and systemic lupus erythematosus.

Authors:  B P Tsao; J M Grossman
Journal:  Curr Rheumatol Rep       Date:  2001-06       Impact factor: 4.592

5.  A novel polymorphism of FcgammaRIIIa (CD16) alters receptor function and predisposes to autoimmune disease.

Authors:  J Wu; J C Edberg; P B Redecha; V Bansal; P M Guyre; K Coleman; J E Salmon; R P Kimberly
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

6.  Identification of therapeutic targets for quiescent, chemotherapy-resistant human leukemia stem cells.

Authors:  Yoriko Saito; Hiroshi Kitamura; Atsushi Hijikata; Mariko Tomizawa-Murasawa; Satoshi Tanaka; Shinsuke Takagi; Naoyuki Uchida; Nahoko Suzuki; Akiko Sone; Yuho Najima; Hidetoshi Ozawa; Atsushi Wake; Shuichi Taniguchi; Leonard D Shultz; Osamu Ohara; Fumihiko Ishikawa
Journal:  Sci Transl Med       Date:  2010-02-03       Impact factor: 17.956

7.  Genetic factors predisposing to systemic lupus erythematosus and lupus nephritis.

Authors:  Paula S Ramos; Elisabeth E Brown; Robert P Kimberly; Carl D Langefeld
Journal:  Semin Nephrol       Date:  2010-03       Impact factor: 5.299

Review 8.  Fc receptors and their role in immune regulation and autoimmunity.

Authors:  Toshiyuki Takai
Journal:  J Clin Immunol       Date:  2005-01       Impact factor: 8.317

Review 9.  Immune cell signaling aberrations in human lupus.

Authors:  S N Liossis; P P Sfikakis; G C Tsokos
Journal:  Immunol Res       Date:  1998-08       Impact factor: 2.829

Review 10.  Genetics of human lupus nephritis.

Authors:  Taro Iwamoto; Timothy B Niewold
Journal:  Clin Immunol       Date:  2016-09-28       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.